hVEGF26-104/RFASE

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamehVEGF26-104/RFASE
Drug Alias Nameanti-VEGF-a vaccine (Immunova)anti-angiogenesis vaccine (Pepscan/Immunovo)anti-angiogenesis vaccine (Immunovo)
ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPepscan Systems
China Registration ClassN/A

Develop Information

Active CompaniesImmunovo BVUniversiteit Van Amsterdam
Inactive CompaniesPepscan Systems
Active IndicationsNeoplasms
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A